Physician profile
Michael L Raff
NPI 1609831080
$6,258.47
in general payments reported to CMS, 2019-2025
21 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what 86% of Corneal and Contact Management providers received nationally (typical 2025 total: $227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $964 · 2020: $590 · 2021: $888 · 2022: $1,149 · 2023: $947 · 2024: $616 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,668.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,667.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,166.33 | 2022-2025 | Infuse, Miebo, Biotrue One Day |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $956.53 | 2019-2021 | |
| Alcon Vision LLC | $894.12 | 2020-2025 | Precision 1, Total30, Precision7 |
| Coopervision INC. | $871.75 | 2019-2025 | Myday Contact Lens, Misight Contact Lens, Clariti Contact Lens |
| Sun Pharmaceutical Industries INC. | $445.97 | 2020-2023 | Cequa |
| Sight Sciences, INC. | $407.42 | 2021-2025 | Tearcare System |
| Horizon Therapeutics Plc | $220.99 | 2022-2023 | Tepezza |
| Lkc Technologies, INC. | $215.78 | 2022-2025 | |
| Tarsus Pharmaceuticals, INC. | $205.09 | 2024-2025 | Xdemvy |
| Shire North American Group INC | $162.26 | 2019 | |
| Biotissue Holdings INC. | $145.18 | 2020-2025 | |
| Menicon America INC | $139.01 | 2019-2020 | |
| Optos, INC. | $99.99 | 2019 | |
| Allergan, INC. | $91.07 | 2022 | |
| Johnson & Johnson Vision Care, INC. | $69.28 | 2020-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $38.80 | 2020 | |
| Maculogix, INC. | $36.04 | 2020-2021 | |
| Kala Pharmaceuticals, INC. | $28.32 | 2021 | |
| Alexion Pharmaceuticals, INC. | $27.37 | 2025 | Koselugo |
| Abbvie INC. | $19.93 | 2025 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Raff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.